| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0002-9343(87)90688-7 |
| P698 | PubMed publication ID | 3303925 |
| P2093 | author name string | L B Reller | |
| M P Weinstein | |||
| C W Stratton | |||
| A Ackley | |||
| H B Hawley | |||
| P433 | issue | 2 | |
| P921 | main subject | osteomyelitis | Q938983 |
| P304 | page(s) | 218-222 | |
| P577 | publication date | 1987-08-01 | |
| P1433 | published in | American Journal of Medicine | Q2842959 |
| P1476 | title | Multicenter collaborative evaluation of a standardized serum bactericidal test as a predictor of therapeutic efficacy in acute and chronic osteomyelitis | |
| P478 | volume | 83 |
| Q33938974 | Ambulatory use of parenteral antibacterials: contemporary perspectives |
| Q37563029 | An alternate pathophysiologic paradigm of sepsis and septic shock: implications for optimizing antimicrobial therapy |
| Q35845962 | Antibiotic efficacy is linked to bacterial cellular respiration. |
| Q40432517 | Antibiotic selection factors and description of a hospital-based outpatient antibiotic therapy program in the USA |
| Q35139518 | Antimicrobial properties of MX-2401, an expanded-spectrum lipopeptide active in the presence of lung surfactant. |
| Q36835821 | Bacterial osteomyelitis in adults: evolving considerations in diagnosis and treatment |
| Q46458071 | Bone-targeting of quinolones conjugated with an acidic oligopeptide |
| Q74798763 | Community-based parenteral anti-infective therapy (CoPAT). Pharmacokinetic and monitoring issues |
| Q37115670 | Continuous cefazolin infusion to treat bone and joint infections: clinical efficacy, feasibility, safety, and serum and bone concentrations |
| Q33559008 | Continuous clindamycin infusion, an innovative approach to treating bone and joint infections |
| Q36757133 | Crossover assessment of serum bactericidal activity and pharmacokinetics of ciprofloxacin alone and in combination in healthy elderly volunteers |
| Q35258426 | Crossover assessment of serum bactericidal activity and pharmacokinetics of five broad-spectrum cephalosporins in the elderly |
| Q36395704 | Current concepts in laboratory testing to guide antimicrobial therapy |
| Q35047705 | Dead bugs don't mutate: susceptibility issues in the emergence of bacterial resistance |
| Q35745822 | Determination of fungicidal activities against yeasts and molds: lessons learned from bactericidal testing and the need for standardization. |
| Q36539662 | Management of postoperative spinal infections |
| Q85232562 | Osteoarthritis in the neonate: risk factors and outcome |
| Q40485550 | Osteomyelitis. Common causes and treatment recommendations |
| Q40526814 | Parenteral versus oral antibiotic therapy. |
| Q37734670 | Peritoneal fluid titer test for peritoneal dialysis-related peritonitis |
| Q37586452 | Pharmacokinetic and pharmacodynamic parameters of antimicrobials: potential for providing dosing regimens that are less vulnerable to resistance |
| Q41359629 | Pharmacokinetic variability of clindamycin and influence of rifampicin on clindamycin concentration in patients with bone and joint infections |
| Q35811353 | Pharmacokinetics and bactericidal activities of one 800-milligram dose versus two 400-milligram doses of intravenously administered pefloxacin in healthy volunteers |
| Q46935155 | Pharmacokinetics and pharmacodynamics of antimicrobial therapy used in child osteoarticular infections |
| Q35767137 | Postoperative infections of the lumbar spine: presentation and management |
| Q33928638 | Principles of selection and use of antibacterial agents. In vitro activity and pharmacology |
| Q35340278 | Randomized clinical trial of aztreonam and aminoglycoside antibiotics in the treatment of serious infections caused by gram-negative bacilli |
| Q37329087 | Selective drug delivery to bone using acidic oligopeptides |
| Q72252519 | Serum bactericidal activity after administration of four cephalosporins in healthy volunteers |
| Q36632471 | Serum bactericidal test |
| Q73778374 | Serum inhibitory titers and serum bactericidal titers for human subjects receiving multiple doses of the antibacterial oxazolidinones eperezolid and linezolid |
| Q28289744 | The Pharmacokinetics and Pharmacodynamics of the Carbapenems: Focus on Doripenem |
| Q77197464 | [Selection of antibiotic-resistant bacteria: microbiological and pharmacological factors] |
Search more.